Stocks · Korea 096240 KOSDAQ

Creverse

8,460원 +0.24% Market cap 866억 2026-10-07 close
Data as of 2026-10-07 · Linked from 6 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER12.05x
PBR1.52x
EPS702 KRW
BPS5,570 KRW
ROE9.82%
DPS800 KRW

Returns and 52-week range

1W+0.59%
1M-4.08%
3M-1.05%
6M-21.67%
1Y-34.72%
YTD-30.83%
52W high13,070원
52W low7,900원
From 52W high-35.27%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
20222,275억257억48억11.3%
20232,335억252억153억10.8%
20242,282억103억66억4.5%
20252,209억22억43억1.0%
Quarterly
2024 4Q551억-3억35억-0.6%
2025 1Q602억28억12억4.7%
2025 2Q547억16억2억2.8%
2025 3Q559억2억86억0.4%
2025 4Q500억-23억-57억-4.7%
2026 1Q584억26억16억4.5%

Company

CEO김형준
Founded2002-06-05
Fiscal year end12
Address: 서울특별시 강남구 테헤란로 521 파르나스타워 21층

Peers in the same sector

CompanyMarket capP/EP/B1M
정상제이엘에스916억13.151.05+0.34%
파로스아이바이오861억—6.18+30.91%
모나용평923억—0.25-3.81%
HLB바이오스텝846억—0.87+100.62%
SM C&C930억—1.14-14.49%
한성크린텍842억783.001.35+1.82%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.